Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Post by wizzdumbon May 01, 2022 4:05pm
426 Views
Post# 34646227

New Presentation Posted

New Presentation Posted

New corporate presentation posted, those of you paying attention may notice some interesting updates. Looks like this will be slide deck for Bloom Burton conference they are presenting at early this week.

 https://microbix.com/wp-content/MBX%20-%20Corp%20PPT%20-%20V2%20-%202022-04-28.pdf

Q2 results May 12, usually see Adelaide update webinar and Q&A session shortly thereafter. 

Building upgrades and massive capacity expansion for QAPs and VTM phasing in over the next few months which will put company on track for hugely expanded revenues and profits in Q4 and beyond. Not a stretch that we could be at 80-100M top line for F2024. Kinlytic still in play and I won't be surprised to see the company funding up to half of what is needed to get it going with the right partner. I continue to accumulate with any free cash at these levels and wish everyone the best going forward into the most exciting times for this company in its long history. 

<< Previous
Bullboard Posts
Next >>